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Nucleostemin (NS) encodes a nucleolar GTP-binding protein highly enriched in the stem cells and cancer
cells. To determine its biological activity in vivo, we generated NS loss- and gain-of-function mouse models. The
embryogenesis of homozygous NS-null (NS/) mice was aborted before the blastula stage. Although the
growth and fertility of heterozygous NS-null (NS/) mice appeared normal, NS/ mouse embryonic fibro-
blasts (MEFs) had fewer NS proteins, a lower population growth rate, and higher percentages of senescent cells
from passage 5 (P5) to P7 than their wild-type littermates. Conversely, transgenic overexpression of NS could
rescue the NS/ embryo in a dose-dependent manner, increase the population growth rate, and reduce the
senescent percentage of MEFs. Cell cycle analyses revealed increased pre-G1 percentages in the late-passage
NS/ MEF cultures compared to the wild-type cultures. We demonstrated that NS could interact with
telomeric repeat-binding factor 1 (TRF1) and enhance the degradation but not the ubiquitination of the TRF1
protein, which negatively regulates telomere length and is essential for early embryogenesis. This work
demonstrates the roles of NS in establishing early embryogenesis and delaying cellular senescence of MEFs
and reveals a mechanism of a NS-regulated degradation of TRF1.
Stem cells are defined by their abilities to self-renew and to
generate multiple cell types in the tissues where they reside.
Expression profile studies indicate that the molecular charac-
teristics of embryonic and somatic stem cells are likely to be
governed by a combination of stem cell-enriched factors rather
than by a single master program (4, 9). One of the stem cell-
enriched genes is nucleostemin (NS), which encodes a novel
nucleolar GTP-binding protein found at high levels in the
neural stem cells, embryonic stem (ES) cells, c-kit bone mar-
row cells, adult testes, and tumor cell lines (24) as well as in the
mesenchymal and stromal stem cells (1, 10) and several types
of human cancers (16).
Perturbation of NS expression in vitro shows that it is re-
quired for maintaining the proliferation of neural stem cells
and some human cancer cell lines by a mechanism not com-
pletely understood (16, 22, 24). The expression of NS does not
correlate completely with cell division (24) or with the sites of
nascent rRNAs and 28S RNA-containing ribosomes (20), sug-
gesting that it is not simply a cell cycle or rRNA-processing
protein. An indication of the NS activity is revealed by its
ability to bind p53, a key factor involved in cell cycle progres-
sion and cellular senescence (24). The interaction between NS
in the nucleolus and p53 in the nucleoplasm is made possible
in the living cells by a GTP-regulated shuttling of NS between
the nucleolar and nucleoplasmic compartments (23). While NS
is essential for maintaining the proliferation of stem cells and
cancer cells in vitro, its function in the developing embryos has
not yet been examined. To determine the physiological roles of
NS, we generated heterozygous NS-null (NS/) mice using
the gene targeting approach and NS-overexpressing mice using
the bacterial artificial chromosome (BAC) transgenic ap-
proach. Our data demonstrate the importance of NS in early
embryogenesis and in the senescence of mouse embryonic fi-
broblasts (MEFs). They also point to an NS-mediated mech-
anism by which the protein stability of telomeric repeat-bind-
ing factor 1 (TRF1) is regulated.
MATERIALS AND METHODS
Gene-targeting vector construction, ES cell electroporation, and NS/mouse
generation. Four BAC clones containing the 129Sv/J genomic sequence of NS
were identified from a screen using BAC mouse ES (Rel II) genomic filters
(Incyte Genomics). Overlapping DNA fragments spanning a 14.3-kb genomic
region were subcloned, which included the entire NS coding sequence, plus 5.1
kb and 2.6 kb of the 5 and 3 sequences (Fig. 1B). A targeting vector was
constructed, which contained a neomycin resistance cassette driven by the phos-
phoglycerate kinase (pgk) promoter, and sandwiched between two LoxP sites
and two flanking recombination arms of 3.5 kb (PstI-StuI) and 4.0kb (HindIII-
EcoRI). The linearized targeting vector was electroporated into 129Sv/J ES cells,
and 384 G418-resistant clones were screened for homologous recombination.
Four correctly targeted ES clones were identified by BamHI-digested genomic
Southern blots using external probes on both sides, two of which (5C and 9B)
were microinjected into C57BL/6-derived blastocysts. Chimeras were bred to
C57BL/6 females, and germ line transmission of the NS-null allele was confirmed
by Southern blots using the 5 and 3 external probes in the F1 agouti offspring
(Fig. 1C).
Isolation of C57BL/6 BAC clones, BAC recombineering, and generation of
NS-BAC transgenic mice. C57BL/6 BAC clones containing the genomic se-
quences of NS were identified by the Ensembl program (www.ensembl.org) and
the UCSC Genome database (genome.ucsc.edu). RP23-102M6 BAC, which con-
tains the longest 5 and 3 sequences, was obtained from BACPAC Resources
(bacpac.chori.org). An internal ribosomal entry site (IRES)-green fluorescent
protein (GFP) expression cassette was inserted into the BAC DNA using a BAC
recombineering technique (see Fig. 4A) (13, 15). After recombination in the host
cells (EL350), the drug selection cassette was excised. BAC DNAs for microin-
jection were prepared using Marlign high-purity columns and linearized by the
PI-SceI enzyme that cuts specifically the pBACe3.6 vector. Digested DNAs were
injected at a concentration of 2.5 g/ml into fertilized eggs derived from FVB
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mice in the transgenic core of the Institute of Biosciences and Technology/
Center for Environmental and Rural Health.
Genotype analysis. For PCR analysis of embryonic day 10.5 (E10.5), E12.5,
E14.5, and 1 week postnatal (postnatal day 7 [PD7]) mice, primer pairs RT387/
RT747 and RT387/RT800 were used to amplify the wild-type (370 bp) and
NS-null (600 bp) alleles, respectively. For genotyping blastocysts, PCRs were
conducted on the wild-type (or NS-null) allele with RT387/RT747 (or RT387/
RT800) for 15 (or 25) cycles. Nested PCRs were set up using 0.5 l of the
first-round reaction mixtures as templates, an internal nested primer RT809, and
the RT747 (for the wild-type allele, 293 bp) or RT800 (for the NS-null allele, 523
bp) primer. Primer pairs RT311/RT519 were used for PCR screening of the NS
BAC transgenic lines. Primer sequences are listed as follows: RT311, 5-GAA
CTT CAA GAT CCG CCA CAA C-3; RT387, 5-ACT CAC AAT GTC AAG
GAC CC TG-3; RT519, 5-TTC TAC AGC TTA GCA TGG CAT TG-3;
RT747, 5-GTG ATG AGT ACA CAA ATG TTG ATG-3; RT800, 5-GCC
TTC TTG ACG AGT TCT TCT G-3; RT809, 5-GAA TAT CCT TTC CAC
AGG ACT G-3.
Detection of mRNA expressions of NS and the GFP transgene by semiquan-
titative reverse transcription (RT)-PCR assays. DNase I-treated total RNAs (1
g) were reverse transcribed into first-stranded cDNAs using random hexamers
and Moloney murine leukemia virus reverse transcriptase (Invitrogen). Target
cDNAs were amplified with odd cycle numbers from 23 to 33, and PCRs within
the linear range were chosen. -Actin was used to control the quantity and
quality of synthesized cDNAs. The primer sequences were shown as follows:
enhanced GFP forward, 5-CAA GCT GAC CCT GAA GTT CAT C-3; en-
hanced GFP reverse, 5-GTT GTG GCG GAT CTT GAA GTT C-3; NS
forward, 5-CAA GCA TTG AGG AAC TAA GAC-3; NS reverse, 5-GCA
ATA GTA ACC TAA TGA GGC-3; -actin forward, 5-AGA GCA AGA
GAG GTA TCC-3; -actin reverse, 5-AGC TCA TAG CTC TTC TCC-3.
MEF culture. MEFs were prepared from E13.5 embryos following a standard
NIH 3T3 cell culture protocol. After removal of the head and visceral portions,
the fibroblastic tissues were minced with razor blades and digested in 0.25%
trypsin-EDTA solution for 2 h at 4°C. Dispersed cells from each animal were
plated in 100-mm plates in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum, glutamine, and antibiotics and grown until conflu-
ence. Serial cultures were carried out in which cells were trypsinized and replated
(106 cells/100-mm dish) every 3 days. One-sixtieth of the total cells were counted
using a Z1 series Coulter counter (Beckman Coulter). The population doubling
level (PDL) was calculated using the formula PDL  log(nf/n0)/log2, where n0
is the initial number of cells and nf is the final number of cells (3).
Senescence-associated -galactosidase assay. Cells were seeded at a density of
3  104 cells per well on 24-well plates and, 3 days later, fixed with 2% formal-
dehyde–0.2% glutaraldehyde for 5 min at room temperature. After phosphate-
buffered saline washes, cells were incubated in the staining solution (150 mM
NaCl, 2 mM MgCl2, 5 mM potassium ferricyanide, 5 mM potassium ferrocya-
nide, 1 mg/ml 5-bromo-4-chloro-3-indolyl--D-thiogalactopyranoside [X-Gal] in
citric acid-sodium phosphate solution, pH 6.0) at 37°C for 16 h.
Statistical analyses. The differences in the PDLs between two MEF cultures
were calculated by repeated measures analysis of variance (ANOVA). The time
when the MEF population reached senescence was determined by estimating
the time when PDL reached zero based on the best-fit curve for each sample.
The differences between two MEF cultures of different genetic backgrounds
were analyzed by t tests. The percentages of senescent cells in every culture were
measured by random sampling on four different positions under low-power views
(10 objective). Each data point represents the average of the results from at
least three MEF cultures derived from different embryos.
Cell cycle analyses. Wild-type and NS/ MEFs were cultured as described
previously. At the time of the analysis, cells were washed, trypsinized, fixed in
72% ice-cold ethanol overnight, and stained with propidium iodide (50 g/ml;
Sigma) in the presence of 20 g/ml DNase-free RNase A. Flow cytometry was
conducted by the M.D. Anderson Cancer Center Flow Cytometry Core Facility,
using a COULTER EPICS XL flow cytometer and the XL System II software.
Cell cycle profiles were compiled from 2  104 gated events and analyzed using
the Multi Cycle AV software. Each data point represents the average of results
from eight independent experiments performed in duplicate (n  16). The
differences in the percentages of the G1, S, G2/M, and pre-G1 cells between the
wild-type and the NS/ MEF cultures were analyzed by t tests.
Cell cultures and transfection. HEK293 cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 5% fetal bovine serum (HyClone),
penicillin (50 IU/ml), streptomycin (50 g/ml), and glutamine (1%). Plasmid
transfections were performed using a standard calcium phosphate method.
Coimmunoprecipitation. For hemagglutinin (HA)-tagged NS and myc-tagged
TRF1 coimmunoprecipitation, HEK293 cells were harvested 2 days after trans-
fection in NTEN buffer (20 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5%
NP-40, 0.1 mM dithiothreitol, supplemented with 1 mM phenylmethylsulfonyl
fluoride, leupeptin [1 g/ml], aprotinin [0.5 g/ml], pepstatin A [0.7 g/ml], and
E64 [1 M]). Cell lysates were incubated with mouse anti-HA (HA.11; Covance)
or anti-myc (9E10; Covance) antibodies for 1 h at 4°C, followed by incubation
with protein G Sepharose beads (Pharmacia) for an additional 4 h at 4°C. For
endogenous NS and TRF1 coimmunoprecipitation, protein complexes were pre-
cipitated from HEK293 cell lysates using anti-NS antiserum (Ab1164, third
bleed) or preimmune antiserum and protein G Sepharose beads. Immunopre-
cipitates were washed extensively with radioimmunoprecipitation assay buffer
(1 phosphate-buffered saline, 0.1% sodium dodecyl sulfate, 0.5% sodium de-
oxycholate, 1% NP-40, supplemented with 1 mM phenylmethylsulfonyl fluoride,
leupeptin [1 g/ml], aprotinin [0.5 g/ml], pepstatin A [0.7 g/ml], and E64 [1
M]), fractionated by 10% sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis, and transferred to Hybond-P membranes (Amersham). Specific signals
were detected by Western blotting with indicated primary antibodies, including
FIG. 1. Generation of an NS-null allele and heterozygous NS-null (NS/) mice. (A) Schematic diagram of the NS genomic and protein
structures. Boxes indicate its 15 exons. Coding exons for the basic (B), coiled-coil (CC), GTP-binding (GTP), and acidic (A) domains are shown
in gray. (B) An NS-null allele was created by replacing the 640-bp proximal promoter and the first 7 1/2 exons with a neomycin selection cassette
(neo). tk, thymidine kinase. (C) BamHI-digested genomic Southern blots of the heterozygous (/) and wild-type (/) F1 mice derived from
the 5C and 9B chimeric founders showed a 5.2-kb or 6.3-kb fragment of the targeted allele when hybridized with the right-arm (RA) or left-arm
(LA) probe. The 14.3-kb fragment represented the endogenous NS allele.
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rabbit anti-myc (A-14; Covance), rabbit anti-HA (polyclonal HA.11), and mouse
anti-TRF1 (TRF-78; Novus) antibodies.
Protein degradation and ubiquitination assays. For protein degradation as-
says, cells were cotransfected with (i) myc-tagged TRF1- and HA-tagged NS-
expressing plasmids or (ii) myc-tagged TRF1-expressing and vector plasmids.
Cycloheximide (100 g/ml) was added 36 h after transfection to block new
protein synthesis. Cell lysates were collected in 1 sample buffer at the indicated
time points and analyzed by immunoblotting with anti-myc (9E10), anti-HA
(HA.11), and anti-	-tubulin antibodies. Signal intensities were measured from
scanned images using the ImageJ 1.36b software (http://rsb.info.nih.gov/ij/). The
results of four independent experiments were plotted such that protein levels at
the 0-h time point were designated as 100%. For in vivo ubiquitination assays,
His-tagged ubiquitin and myc-tagged TRF1 were coexpressed with or without NS
in HEK293 cells, followed by MG-132 treatment (12.5 M for 12 h) to inhibit
proteasome function. Cell lysates were harvested in NTEN buffer. Ubiquitinated
TRF1 was detected by the mouse anti-TRF1 (TRF-78) antibody as the high-
molecular-weight species.
RESULTS
Generation of an NS-null allele. The NS coding sequence is
composed of 15 exons in the genome (Fig. 1A). The first three
exons encode a basic domain that mediates its nucleolar tar-
geting and p53 interaction (24). The GTP-binding domain,
which regulates the partitioning of NS between the nucleolus
and the nucleoplasm (23), is located from the sixth to the ninth
exons. An NS-null allele was created by replacing a 640-bp
promoter region and the first 7 1/2 coding exons with a neo-
mycin selection cassette (Fig. 1B). Four ES clones were iden-
tified that exhibited the correct Southern pattern of a 14.3-kb
endogenous band and a 6.3-kb (or 5.2-kb) targeted band when
hybridized with the left (or right) arm probe. Two ES clones
(5C and 9B) were injected into C57BL/6 blastocysts, and chi-
meric mice were bred with C57BL/6 mice to obtain germ line
transmission of the NS-null allele (Fig. 1C).
Early embryonic lethality of NS/ mice. The first genera-
tion (F1) NS
/ mice were viable and displayed no overt signs
of growth defect or infertility. By contrast, no viable NS/
mice were detected at PD7 from intercrossing the NS/ mice
(Table 1). The wild-type-to-heterozygous-to-homozygous ratio
followed a typical Mendelian ratio of 1:1.9:0 for homozygous
lethality. To determine the affected developmental age, geno-
type analyses were carried out at E3.5 and E10.5. The wild-
type-to-heterozygous-to-homozygous ratios were determined
to be 1:1.7:0 (n  101) and 1:2:0 (n  83) for the E3.5 and
E10.5 embryos, respectively. These results show that the NS
function is essential for the blastocyst formation and are con-
sistent with its high expression level in ES cells.
Increased senescence of NS/MEFs. The apparent normal
development and fertility of NS/ mice suggests that these
animals are capable of either up-regulating the expression of
the remaining wild-type NS allele or functioning at a 50%
reduced NS level under physiological conditions. In the latter
case, a haploid genotype may be insufficient to support the NS
activity under stress conditions. To examine these possibilities,
MEFs were derived from the NS/ embryos and their wild-type
littermates and examined for their NS expression levels, doubling
rates, and percentages of senescent cells over passages. Western
analyses showed that the NS expression in both the wild-type and
the NS/ MEF cultures gradually decreased over passages (Fig.
2A). By comparison, wild-type MEFs expressed NS at a higher
level than did the NS/ MEFs of the same passages (Fig. 2A;
also see Fig. S1A in the supplemental material), excluding the
possibility that the remaining wild-type NS allele upregulated its
expression in the NS/ cells. The PDL (see Materials and Meth-
ods) of the NS/ MEFs (from 6 embryos) began to fall below
that of the wild-type cells (from 9 littermates) from passage 4 (P4)
TABLE 1. Genotypes of offspring from intercrosses of NS/ mice
Age
No. with genotype No.
resorbed Total Ratio
b
/ / /
1 wk 30 58 0 NAa 88 1:1.9:0
E10.5 28 55 0 3 83 1:2.0:0
E3.5 38 63 0 NA 101 1:1.7:0
a NA, not available.
b Ratio of / to / to / mice.
FIG. 2. Expression of NS protein and population doublings were decreased in the NS/ MEFs compared to the wild-type (WT) cells. (A) The
expression levels of NS protein in the WT and NS/ MEFs from P1 to P7 were determined in parallel by Western blot analyses using an anti-NS
antibody (Ab2438). Anti-	-tubulin immunoblots were used as loading references (	-Tub). (B) The PDLs (y axis) in the NS/ (black) and WT
(gray) MEF cultures were plotted from P1 to P8 (x axis). PDLs were calculated using the formula PDL  log(nf/n0)/log2, where n0 is the initial
number of cells and nf is the final number of cells. Error bars represent standard errors of the means.
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to P8 (P
 0.0001 by repeated measures ANOVA) (Fig. 2B). Yet,
the NS/ and wild-type MEF cultures both reached growth
plateaus at P7.
The reduced population doubling number of the NS/
MEF culture after P3 can be explained by an increase in the
cell cycle length or in the number of cells going into senes-
cence. To differentiate these two possibilities, the numbers of
senescent cells in the P2 to P8 cultures were measured by the
FIG. 3. NS haploinsufficiency led to increased numbers of senescent cells in the P5 to P7 MEF cultures. Representative views of the senescent cells,
detected by the SA--Gal assay in the top panels, and the total numbers of cells, determined by DAPI nuclear staining in the bottom panels, were shown
for the P7 NS/ (A1) and wild-type (WT, A2) MEF cultures. Arrows indicate SA--Gal cells. Bars, 100 m. (B) The percentages of SA--Gal cells
were increased in the NS/ MEF culture (black bars) compared to the WT culture (gray bars) from P5 to P7 (top panel). Error bars represent standard
errors of the means. Means ( standard errors of the means) and P values are provided in the bottom panel.
FIG. 4. Creation of NS-overexpressing mice. (A) An NS gain-of-function mouse model was made by a BAC transgenic approach. An IRES-GFP cassette
was engineered after the stop codon of NS. The targeting vector contained a LoxP-flanked pgk-neomycin cassette (pgkNeo), a partial 3 sequence of NS before
the stop codon, an IRES sequence, and a GFP reporter gene, sandwiched by two recombineering arms. The pgkNeo cassette was excised from the recombined
BAC clone (BAC: NSGFPNeo), leaving a LoxP site in the nonconserved region of the 13th intron. All genomic sequences were preserved in the final transgene
construct (BAC: NSGFP), including 150 kb upstream and 68 kb downstream of the NS locus. Lines a and b indicate primers used for genotype analyses. The
transgenic allele will generate a 4.6-kb fragment in BamHI-digested Southern blots hybridized with the right-arm probe (RA). (B) Four transgenic lines with
different levels of transgene dosage were detected by PCRs (TG). RNA polymerase II (PolII) PCRs were used as controls for the genomic DNA preparations.
(C) The mRNA expression levels of the GFP and NS in the adult testis were measured by semiquantitative RT-PCRs. RT-minus [RT()] and -actin (ActB)
reactions were used as negative and positive controls. Amplification cycle numbers for panels B and C are indicated on the right.
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senescence-associated -galactosidase (SA--Gal) assay (Fig.
3A). Before P5, the percentages of senescent cells in the
NS/ and wild-type MEF cultures were statistically indistin-
guishable from each other. From P5 to P7, the percentages of
SA--Gal cells in the NS/ MEF cultures were higher than
those in the wild-type cultures (Fig. 3B) (P  0.05). At P8, the
SA--Gal cell percentage in the wild-type culture increased
to the same level as in the NS/ culture. These results dem-
onstrate that NS haploinsufficiency can increase the number of
MEFs going into senescence in the P5 to P7 cultures.
Creation of NS overexpression transgenics and phenotypic
rescue of the NS/ embryo. To support the knockout results
from a gain-of-function angle, we generated mice that overex-
pressed NS but still maintained its endogenous transcriptional
regulation. To do so, a BAC transgene was used that contained
a 225-kb genomic fragment of the NS locus. An IRES-GFP
cassette was engineered after the stop codon of NS to facilitate
transgene detection both at the genomic and the mRNA levels
(Fig. 4A). Four transgenic lines were established. PCR analy-
ses of the F1 genomic DNAs showed that lines TG#17 and
TG#3 harbored the highest copy number of the transgene,
followed by TG#1 and TG#5 (Fig. 4B). The absolute copy
number of transgenes per allele was later measured by com-
paring the intensities of the transgene and the NS-null frag-
ments in the NS/ TG/ genomic Southern blots (Fig. 5A).
Semiquantitative RT-PCRs demonstrated that line TG#17 ex-
pressed the highest level of GFP and NS in the adult testis,
followed by lines TG#3, TG#1, and TG#5 in decreasing order
(Fig. 4C).
To test if the BAC transgene could functionally rescue the
NS/ embryo, compound heterozygous mice (NS/ TG/)
were mated with the NS/ mice. Their offspring were geno-
typed by Southern blots in which the endogenous NS, the
NS-null, and the NS transgene alleles would generate 14.3-kb,
5.2-kb, and 4.6-kb fragments, respectively (Fig. 5A). Due to the
transfer inefficiency of large-sized fragments and the length of
the right-arm probe (250 bp), the signal intensity of the 14.3
kb band appeared weaker than that of the 5.2-kb band.
FIG. 5. NS transgene rescued homozygous NS-null (NS/) embryos in a dose-dependent manner. (A) To rescue NS/ mice using the
transgenic alleles, compound heterozygous mice (NS/ TG/) were crossed with NS/ mice. The genotypes of their bigenic offspring were
determined by Southern blots in which the NS transgene, NS-null, and endogenous NS alleles would yield 4.6-kb, 5.2-kb, and 14.3-kb fragments,
respectively. Pups 4, 5, and 7 represented NS/ TG/ mice or embryos. The transgene copy numbers, determined by the intensity ratios between
the transgene and the NS-null allele, were 2, 1, and 4 for the TG#1, TG#5, and TG#17 lines, respectively. (B) The high-expression TG#17 line
could functionally rescue NS/ embryos into adulthood. By contrast, the lower-copy-number TG#1 could rescue the NS-null embryos only up
to E12.5. The rescue probability of the TG#1 allele dropped significantly between E12.5 and E14.5. Although identifiable at E12.5, NS/
TG#5/ embryos appeared developmentally delayed. The predicted ratios for rescue and no rescue are shown. (C) Hematoxylin-eosin
immunohistochemistry of the sagittal sections of the whole NS/ TG#1/, NS/ TG#5/, and NS/ embryos at E12.5 are shown in the top
panels of C1, C2, and C3, respectively. Higher magnifications of the heart are shown in the bottom panels. The outflow track (pulmonary trunk
and aorta) and the right ventricle of the NS/ TG#1/ embryo were underdeveloped. In addition to dilated atria and small ventricles, the
pulmonary trunk and aorta of the NS/ TG#5/ embryo were in the wrong position, indicating an outflow track-remodeling defect. Abbrevi-
ations: FB, forebrain; MB, midbrain; HB, hindbrain; H, heart; Lv, liver; Lg, lung; Br, bronchus; Es, esophagus; GI, gastrointestinal tract; RV, right
ventricle; A, atrium; PT, pulmonary trunk; Ao, aorta; AV, atrioventricular cushion. Bars: 1 mm (top panels), 300 m (bottom panels).
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From the NS/ TG#17/ and NS/ intercross, the NS/
TG#17/ to NS/ TG#17/ to total ratio was determined
to be 3-13-34 at PD7 (Fig. 5B). The rescued NS/ TG#17/
mice were indistinguishable from the wild-type mice in their
development, growth, and mating capabilities. To determine if
the TG#1 allele, which had a lower transgene copy number
than the TG#17 allele, was able to rescue the NS/ embryos,
we genotyped the offspring from the NS/ TG#1/ 
NS/ intercross. After testing 25 mice at PD7, 8 compound
heterozygous mice NS/ TG#1/ were generated, but no
rescued mice (NS/ TG#1/) were identified. To further
define the developmental age when NS/ TG#1/ embryos
died, we harvested embryos from the NS/ TG#1/ 
NS/ mating at E10.5, E12.5, and E14.5. Genotyping results
showed that the percentage of NS/ TG#1/ embryos
dropped significantly between E12.5 and E14.5. At E14.5, 4 of
7 embryos from 3 litters were compound heterozygous, and
none were rescued embryos (Fig. 5B). Although the gross
tissue morphology of the E12.5 TG#1-rescued embryo (NS/
TG#1/) appeared normal (Fig. 5C1, top panel) at the organ
level, the NS/ TG#1/ embryo had a smaller right ventri-
cle and a shorter outflow tract than did the NS/ embryo (Fig.
5C1 and C3, bottom panels). From the NS/ TG#5/ 
NS/ mating, we were able to identify NS/ TG#5/ em-
bryos at E12.5 but not at PD7 (Fig. 5B). The E12.5 NS/
TG#5/ embryo displayed severe cardiac defects, including
distended atria, small ventricles, and a double-outlet right ven-
tricle with overriding aorta (Fig. 5C2). These findings demon-
strate that the NS transgene is functionally capable of rescuing
the NS-null allele in a dose-dependent manner. The TG#17
allele is able to fully rescue NS/ mice into adulthood. The
lower-copy-numbered TG#1- and TG#5-rescued embryos die
between E12.5 and E14.5 due to developmental defects in the
heart.
Transgenic overexpression of NS increased the population
doubling and decreased the senescence of MEFs. To support
our findings in the NS/ MEF culture, we determined the
effect of NS overexpression on the MEFs derived from the
heterozygous TG#1 (TG#1/) embryos chosen for their
moderate level of NS overexpression. Western analyses
showed that the NS expression in the TG#1 MEF cultures also
gradually decreased over passages (Fig. 6A). Comparing cul-
tures of the same passage, TG#1 MEFs expressed NS at a
higher level than did the wild-type MEFs (Fig. 6A; also see Fig.
S1B in the supplemental material). The NS protein amount of
the TG#1 MEFs was 1.4 ( 0.09) times that of the wild-type
cells. Concordantly, the PDL in the TG#1 MEF cultures (from
3 embryos) began to show some increases over the wild-type
MEFs (from 6 littermates) from P5 to P8 (P 
 0.001 by re-
peated measures ANOVA) (Fig. 6B). Despite this increase, a
moderate overexpression of NS in the TG#1 MEF cultures did
not alter their time to reach the population growth plateau
FIG. 6. Overexpression of NS at a moderate level reduced the senescent cell percentage in the P6 and P7 MEF cultures. (A) Protein expression
levels of NS in the WT and TG#1 MEFs from P1 to P6. Anti-	-tubulin immunoblots were used as loading controls (	-Tub). (B) PDLs of the TG#1
and WT MEF cultures over 8 passages was shown in black and gray, respectively. (C1) The percentages of SA--Gal cells were decreased in the
TG#1 MEF cultures (black bars) compared to the WT cultures (gray bars) from P6 to P7. Error bars represent standard errors of the means in
panels B and C1. Means ( standard errors of the means) and P values are shown in panel C2.
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compared to the wild-type MEF cultures. Opposite to the
NS/ cells, the percentages of SA--Gal cells in the P6 and
P7 TG#1 MEF cultures were reduced compared to the wild-
type cultures (P 
 0.05) (Fig. 6C). These results demonstrate
that NS overexpression can decrease the number of senescent
cells between P6 and P7 and support the phenotypes observed
in the NS/ MEFs.
Next, we sought to determine if the level of NS overexpres-
sion affected the degree of senescence by determining the
growth and senescence of the TG#17 MEFs, which expressed
NS at the highest level among the four transgenic lines. West-
ern analyses showed that TG#17 MEFs expressed the NS
protein at a level higher than that of the wild-type MEFs, and
similar to both the wild-type and TG#1 cells, their NS expres-
sion decreased over passages (Fig. 7A; also see Fig. S1C in the
supplemental material). The NS protein amount of the TG#17
MEFs was 2.9 ( 0.2) times that of the wild-type cells. Notably,
the PDL of the TG#17 MEF cultures (from 4 embryos, 8
cultures) was initially reduced compared to the wild-type MEF
cultures (from 4 littermates, 8 cultures) at P2 and P3 (P
 0.01)
but began to exceed the wild-type PDL from P6 (Fig. 7B). As
a result, the TG#17 MEF culture was able to maintain some
mitotic activities at P8, whereas the wild-type MEF culture
reached a population growth plateau around P6. The growth
plateau time in vitro was 3 days longer in the TG#17 MEF
culture (22.1  0.7 days in vitro) than in the wild-type MEF
culture (19.1.1  0.5 days in vitro) (P  0.004, n  8). This
increase in the population growth rate of the TG#17 MEFs at
later passages correlated with a decreased number of cells
undergoing senescent changes. From P6 to P8, the percentages
of SA--Gal cells in the TG#17 MEF cultures were signifi-
cantly reduced compared to the wild-type cells cultured in
parallel (P 
 0.01 for the P6 and P7 cultures, P 
 0.02 for the
P8 cultures) (Fig. 7C). These data show that, although a high-
level NS overexpression has a detrimental effect on cell growth
initially, it becomes favorable for cell proliferation and longev-
ity in the late-passage cultures where the NS expression is low.
The P4 and P5 NS/ MEF cultures have higher pre-G1
percentages than the wild-type cultures of the same passages.
To study the partial loss-of-function effect of NS on the cell
cycle profile, NS/ and wild-type MEFs were collected from
8 embryos each, cultured in duplicate, and analyzed for their
cell cycle profiles from P3 to P5. The cell cycle study revealed
two differences between the NS/ and the wild-type MEF
cultures (Fig. 8). First, the NS/ MEFs exhibited higher
pre-G1 percentages, which represented apoptotic cells, than
the wild-type MEFs at P4 and P5 (Fig. 8A). Second, the G2/M
percentages of the NS/ cultures increased from P3 to P5
(P 
 0.001), whereas no statistical difference was seen between
the G2/M percentages of the P3 and P5 wild-type cultures (P
0.11, n  16). Both the NS/ and the wild-type MEF cultures
showed a decrease in the S-phase cells in the P5 cultures
compared to the P3 cultures (P 
 0.001 and  0.03 for the
NS/ and wild-type cells, respectively) or the P4 cultures (P
0.02 and 0.03 for the NS/ and wild-type cells, respectively).
No statistical differences were seen in the G1- or S-phase per-
centages between the NS/ and wild-type cultures of the
same passages. These results indicate that a partial loss of NS
FIG. 7. MEFs overexpressing NS at a high level had a longer life span and fewer senescent cells than did the WT MEFs. (A) Protein expression
levels of NS in the WT and TG#17 MEFs from P1 to P8. Anti-	-tubulin immunoblots were used as loading controls (	-Tub). (B) PDLs of the
TG#17 and WT MEF cultures over 9 passages are shown in black and gray, respectively. (C) Percentages of SA--Gal cells were decreased in
the TG#17 MEF cultures (black bars) compared to the WT cultures (gray bars) from P6 to P8. Error bars represent standard errors of the means
in panels B and C1. Means ( standard errors of the means) and P values are shown in panel C2.
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function will lead to an increased number of apoptotic cells
and a cell cycle blockage in the G2/M phase in the late-passage
MEFs.
NS interacts with and destabilizes the TRF1 protein. The
telomere length is maintained by the telomerase (TERT) (2, 8,
18) and several telomere-binding proteins, including TRF1
(26), TRF2 (6), and TRF1-interacting nuclear protein 2
(TIN2) (12). Given the role of NS in cellular senescence, we
hypothesized that NS might modulate one of the telomere-
binding proteins. To test this idea, we examined the interaction
between NS and these proteins in vivo in HEK293 cells trans-
fected with both HA-tagged NS and myc-tagged candidate
genes for coimmunoprecipitation. Among them, only TRF1
was able to bind NS strongly in this assay. We showed that NS
could be coimmunoprecipitated with TRF1 by the anti-myc
antibody (Fig. 9A1, first row, left column) but not by the
mouse immunoglobulin G (right column). Similarly, TRF1
could be detected in the NS protein complex precipitated by
the anti-HA antibody (third row, left column). We confirmed
this in vivo interaction by showing that the endogenous TRF1
in HEK293 could be copurified with the endogenous NS pro-
tein complex precipitated by the anti-NS antiserum, but not by
the control preimmune serum (Fig. 9A2). In addition, we dem-
onstrated that there was no detectable interaction between NS
and another TRF1-interacting protein, TIN2 (Fig. 9A3, 1st
row, left column), suggesting that NS bound TRF1 when TRF1
was not associated with the telomeres.
After its release from the telomere, the TRF1 protein was
subjected to the ubiquitin-proteasome-mediated degradation
pathway (5). To determine if NS regulated the protein stability
of TRF1 in vivo, HEK293 cells were cotransfected with HA-
tagged NS (or control plasmids) and myc-tagged TRF1. Thirty-
six hours after transfection, cycloheximide (100 g/ml) was
added to block new protein synthesis, and lysates were col-
lected at 2-h intervals from 0 to 12 h. Our results showed that,
in the NS-transfected cells, the rate of TRF1 protein degrada-
tion was significantly accelerated compared to the control
transfected samples (Fig. 9B). Using this assay, we estimated
the TRF1 protein half-life to be 4.9 ( 0.4) h in the NS-
transfected cells and 7.6 ( 0.6) h in the control transfected
cells (P  0.005) based on the analysis of four independently
conducted experiments (Fig. 9C). Consistent with the lack of
binding between NS and TIN2, NS did not affect the protein
stability of TIN2 measured by the same method (Fig. 9D and
E). Because the protein stability of TRF1 was regulated by the
ubiquitin-proteasome pathway, we examined whether NS had
an effect on the ubiquitination of TRF1 protein in vivo. His-
tagged ubiquitin (His-Ub) and NS (or control vector) were
coexpressed in HEK 293 cells, and the ubiquitination patterns
of the TRF1 protein in the NS-expressing or control samples
were revealed by anti-TRF1 Western blots. Despite the obvi-
ous ubiquitination of whole-cell proteins after the His-Ub
transfection and MG132 treatment, coexpression of NS did not
increase the amount of high-molecular-weight TRF1 bands
compared to the control lysates receiving the same treatment
(Fig. 9F). Together these results show that NS is capable of
increasing the protein turnover of TRF1 without affecting its
ubiquitination level.
FIG. 8. The pre-G1 percentage was elevated in the P4 and P5 NS
/ MEF cultures compared to the WT cultures of the same passages.
(A) MEF cultures derived from 8 NS/ and 8 WT embryos of 3 different litters were examined for their cell cycle profiles at P3, P4, and P5. Every
culture was analyzed in duplicate. The average percentages of the G1, S, G2/M, and pre-G1 phase cells were summarized as means  standard
errors of the means in panel A1 for P3 cultures, panel A2 for P4 cultures, and panel A3 for P5 cultures. Statistical analyses showed that the pre-G1
cell percentages were higher in the NS/ cultures than in the WT cultures at P4 and P5. Representative cell cycle profiles of the P4 (B1) and P5
(B2) NS/ and WT MEF cultures are shown. x axes represent the propidium iodide (PI) intensities; y axes represent the event frequencies.
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FIG. 9. NS interacted with TRF1 and negatively regulated its protein stability. (A) The interaction between NS and TRF1 was shown by in vivo
coimmunoprecipitation assays. HEK293 cells were cotransfected with HA-tagged NS and myc-tagged TRF1 and immunoprecipitated with the anti-myc
antibody (first and second rows, left columns), anti-HA antibody (third and fourth rows, left columns), or mouse immunoglobulin G (first to fourth rows,
right columns). The copurified proteins (first and third rows) and the immunoprecipitates (second and fourth rows) were detected by Western analyses
using the indicated antibodies. (A2) The endogenous TRF1 could be copurified with the endogenous NS in HEK293 cells immunoprecipitated by the
anti-NS antiserum (Ab1164) but not by the preimmune serum (PreI). The NS immunoprecipitates are analyzed in the bottom panel. (A3) NS failed to
bind a TRF1-interaction protein, TIN2, in coimmunoprecipitation assays in which HEK293 cells were transfected with HA-tagged NS and myc-tagged
TIN2 and immunoprecipitated with the anti-myc antibody. (B) The effect of NS on the TRF1 protein stability was examined by a protein degradation
assay in which myc-tagged TRF1 and HA-tagged NS (or control vector, Ctrl) were coexpressed in HEK293 cells. Thirty-six hours after transfection, living
cells were treated with cycloheximide for 0 to 12 h at 2-h intervals. The amounts of TRF1 and NS proteins were determined by anti-myc and anti-HA
Western blots, respectively. Anti-	-tubulin (	-Tub) Western blots were used as loading controls. (C) The amounts of TRF1 protein at every time point
were measured quantitatively from scanned images of four protein degradation experiments using the ImageJ 1.36b software and expressed as a
percentage of the TRF1 protein amount at the 0-h time point. (D, E) Coexpression of NS did not alter the TIN2 protein stability examined by the same
assay. The amounts of TIN2 and NS proteins were determined by anti-myc and anti-HA Western blots. Anti-	-tubulin (	-Tub) immunoblots were used
as loading controls. The amounts of TIN2 protein at every time point were expressed as a percentage of the TIN2 protein amount at the 0-h time point.
(F) The NS effect on the ubiquitination of TRF1 protein was measured in vivo by expressing His-tagged ubiquitin (His-Ub) and NS (or control plasmid)
in HEK293 cells treated with a proteasome inhibitor MG132. TRF1 protein was detected by anti-TRF1 Western blots. Lysates were blotted with the
anti-His antibody to show the ubiquitination effect (Ub) and the anti-	-Tub antibody for loading controls. Coexpression of NS did not increase the
high-molecular-weight species of TRF1 (Ub-TRF1) compared to the control samples.
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DISCUSSION
In this report, we demonstrate that a complete NS loss of
function causes embryonic lethality as early as E3.5, consistent
with its high expression in ES cells. NS haploinsufficiency re-
duces the population doubling levels in the MEF culture,
which correlates with increases in the percentage of cells en-
tering senescence from P5 to P7. Cell cycle analyses show that
the NS/ MEF cultures contain more pre-G1 cells than the
wild-type cultures do at P4 and P5, indicating an increased
number of apoptotic cells. These phenotypes of NS haploin-
sufficiency are supported by a BAC transgenic model that
elevates the expression of NS in a physiological manner. MEF
cultures derived from this transgenic model display an in-
creased population doubling number and a decreased SA--
Gal cell percentage at late passages compared to the wild-
type cultures. In the high-NS-expressing transgenic line, the
mitotic activity of the MEF cultures is maintained for several
more days after the wild-type MEFs cease to proliferate. These
data place NS among a few genes, including TRF1 (11) and
MDM2 (17), whose deletions were shown to cause embryonic
lethality around implantation and provide functional evidence
connecting a stem cell pathway with cellular aging.
Common causes for cellular senescence include reactive
oxygen species, telomere attrition, genomic damages, and the
ras oncogene. Oxidative stress is the major factor for mouse
cells in culture to become senescent (19). NS is predominantly
distributed in the nucleolus. Several nucleolar proteins, as well
as a disruption of the nucleolar structure (21), are involved in
p53 transactivation in response to a variety of cellular stresses.
Despite the observation that NS could bind p53 (24), we did
not detect any significant changes in the p53 expression level in
the partial loss-of-function MEFs (see Fig. S2 in the supple-
mental material). Instead, we uncovered an interaction be-
tween NS and a telomere-binding protein, TRF1, and demon-
strated that NS could increase the rate of TRF1 protein
degradation. TRF1 provides a negative feedback mechanism
for telomere length maintenance by blocking the access of
telomerase to and the elongation of telomeres (25). In addition
to its role in telomere maintenance, targeted deletion of TRF1
causes early embryonic lethality (day 5 to 6 postcoitus), sug-
gesting that murine TRF1 has an essential function in early
embryogenesis independent of telomere length regulation
(11). Based on our findings, we propose that one of the func-
tions of NS is to facilitate the degradation of TRF1, which
promotes the elongation of telomeres and protects continu-
ously dividing cells from telomere attrition (Fig. 10A). Because
NS fails to increase the ubiquitination of TRF1, this activity of
NS may occur after the ubiquitination step. This effect of NS
may influence the aging of human cells more than it does on
the mouse cells, which are known to senesce with high telo-
merase activities and long telomeres, and may also regulate the
non-telomere-related functions of TRF1 during early embryo-
genesis and in the cell cycle checkpoint control. An F-box
protein, FBX4, has been shown to promote the TRF1 protein
degradation (14), suggesting a possible connection between NS
and the FBX4-mediated pathway.
In our NS gain-of-function paradigms, the PDL increase
(PDL) in the TG#17 MEFs was notably less than that of the
wild-type MEFs in the P1 and P2 cultures but began to surpass
the wild-type PDL as the expression of NS started to decrease
at later passages. These results suggest that an NS gain-of-
function phenotype can only be achieved by an optimal level of
overexpression and that a high-level overexpression of NS may
inversely affect cell proliferation. Supporting this idea, tran-
sient overexpression of NS in U2OS cells was shown to cause
a cell cycle block between the late-S and G2 phases (24). In
FIG. 10. NS regulates the protein stability of TRF1 and controls cell proliferation and senescence. (A) Our findings support a model in which
NS promotes the degradation of TRF1 protein without affecting its ubiquitination level. This activity of NS will favor the removal of TRF1 from
the telomeres and allow telomerase to access and elongate the telomere. (B) NS exerts a threshold effect on dividing cells. Cells undergo
continuous proliferation when their NS expression levels (y axis) are within a certain threshold (between H and M). When the expression of NS
drops below the M point, cells begin to enter into senescence. Most cells will become mitotically inactive when NS falls below the low level (L).
Paradoxically, excessive amounts of NS will inhibit cell proliferation, as seen in the P1 and P2 cultures of TG#17 MEFs. Over passages, NS
expression in the NS/ MEFs begins to fall below the M level first, followed by the WT, TG#1, and TG#17 cells, which explains why the effect
of NS perturbation in these models is most obvious between P5 and P8.
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addition, we selected stable U2OS cell lines that expressed a
hemagglutinin-tagged NS transgene at different levels and
demonstrated that the low-overexpression lines (clones 9 and
B1) had a clear growth advantage over the wild-type cells,
whereas the moderate (clone 1)- and high (clone 12)-overex-
pression lines displayed a similar or slowed growth rate com-
pared to the control (see Fig. S3 in the supplemental material).
In the MEF cultures, this negative effect of a high-level NS
overexpression on cell proliferation turns into a positive one
when the transcriptional activity controlling the NS expression
decreases at later passages. As a result, the TG#17 MEF
culture is able to maintain some mitotic activities after P7.
Unlike the TG#17 cells, the NS/, TG#1, and wild-type
MEF cultures become mitotically inactive at about the same
time, indicating that the population growth plateau time in
those cultures is determined primarily by the senescence-trig-
gered downregulation of NS at P7. These results suggest a
model in which cell proliferation and senescence are controlled
by a threshold level of NS (Fig. 10B). Because the NS expres-
sion gradually decreases over passages, the NS/ MEFs
become the first to reach this threshold, followed sequen-
tially by the wild-type, TG#1, and TG#17 MEFs, which
explains why the differences in the PDL and SA--Gal
percentage between the NS/, wild-type, TG#1, and
TG#17 MEF cultures are most obvious from P5 to P7.
The loss of NS expression over passages in the transgenic
MEFs is a result of the BAC transgenic design that retains the
endogenous transcriptional control on the transgenic alleles.
By comparing the Southern intensities of the transgenic and
the NS-null alleles of the NS/ TG/ mice (Fig. 5A), we
estimate the transgene copy numbers to be 2, 1, and 4 for
TG#1, TG#5, and TG#17, respectively. While the TG#17
allele can rescue NS/ embryos in vivo into adulthood, the
TG#1 and TG#5 alleles are able to do so only until E12.5
(TG#1) or before (TG#5). Compared to the NS/ litter-
mates, the right ventricle and the outflow track of the TG#1-
rescued E12.5 embryo (NS/ TG#1/) were underdeveloped.
Consistent with the transgene copy number, the NS/
TG#5/ embryo had even more severe cardiac phenotypes
than the NS/ TG#1/ embryo, which include distended
atria, small ventricles, and a double-outlet right ventricle with
overriding aorta. The fact that the TG#5 and TG#1 alleles fail
to rescue NS/ embryos completely argues that, on a per-
copy basis, the NS transgene is expressed at a lower level than
the endogenous NS allele and that NS plays a critical role in
the cardiac development around E12.5, which may not be
revealed by our MEF studies. Failure of the NS/ embryo to
pass the blastula stage and the TG#1- and TG#5-rescued
embryos to pass E14.5 demonstrate a lack of in vivo compen-
satory mechanisms for the NS function during the early and
mid-embryonic development. Two NS-related genes, GNL3L
(guanine-nucleotide binding protein 3-like protein) and Ngp1,
are found in humans and rodents. Phylogenetically, NS and
GNL3L are more closely related to each other than to Ngp1. A
previous study showed that the human GNL3L gene was able
to complement the function of Grn1p (the yeast homologue of
NS and GNL3L) in fission yeasts, but the human NS failed to
do so (7). Given that all three genes (NS, GNL3L, and Ngp1)
are expressed in the mouse ES cells (unpublished data), our
findings support the idea that NS has functionally diverged
from GNL3L and Ngp1 in mice.
In summary, this work provides the first in vivo evidence
demonstrating the essential role of NS in early embryogenesis.
We also show that the endogenous expression level of NS
inversely correlates with cellular senescence. Lowering or ele-
vating NS expression is able to increase or decrease the senes-
cence of MEFs, respectively. Finally, NS provides a link be-
tween stem cells and the aging process through its regulation of
TRF1 protein stability.
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